Form D · Biotechnology
Elastro, Inc.
Watertown, MA · CIK 0002076219
Offering snapshot reported Aug 15, 2025 · SEC filing
- Reported sold
- $2.33M Offering amount: $2.33M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2025 | Initial | $2,325,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-554957
Source: Form D, filed Aug 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jia Liu | Director |
| Ren Liu | Director |
| Robert Mark Richardson | Director |
| Michael Schrader | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
94 Union St
Watertown, MA, 02472
Watertown, MA, 02472